These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia. Favaloro EJ Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513 [TBL] [Abstract][Full Text] [Related]
43. Thrombotic outcomes in patients in a large clinical enterprise following COVID-19 vaccination. Patterson WM; Greene BD; Tefera L; Bena J; Milinovich A; Mehta N; Chung MK; Kapadia S; Svensson LG; Cameron SJ J Thromb Thrombolysis; 2023 Apr; 55(3):426-431. PubMed ID: 36653575 [TBL] [Abstract][Full Text] [Related]
44. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination. van de Munckhof A; Krzywicka K; Aguiar de Sousa D; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi M; Arnold M; Ferro JM; Coutinho JM Eur J Neurol; 2022 Jan; 29(1):339-344. PubMed ID: 34536256 [TBL] [Abstract][Full Text] [Related]
45. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis. Dorgalaleh A; Shabannezhad A; Hassani S Ann Hematol; 2023 Nov; ():. PubMed ID: 38030893 [TBL] [Abstract][Full Text] [Related]
47. Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2. Pang X; Liu H; He X; Ji T; Zhu Y; Cui Y Front Immunol; 2021; 12():782335. PubMed ID: 35095856 [TBL] [Abstract][Full Text] [Related]
49. Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions. Thakur KT; Tamborska A; Wood GK; McNeill E; Roh D; Akpan IJ; Miller EC; Bautista A; Claassen J; Kim CY; Guekht A; Pardo CA; Williams O; García-Azorín D; Prasad K; Schmutzhard E; Michael BD; Chou SH; Winkler AS; Solomon T; Elkind MS J Neurol Sci; 2021 Aug; 427():117532. PubMed ID: 34134058 [TBL] [Abstract][Full Text] [Related]
50. Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report. Di Pietro M; Dono F; Consoli S; Evangelista G; Pozzilli V; Calisi D; Barbone F; Bonanni L; Onofrj M; De Angelis MV; Sensi SL Neurol Sci; 2022 May; 43(5):2951-2956. PubMed ID: 35217969 [TBL] [Abstract][Full Text] [Related]
51. Vaccine-induced massive pulmonary embolism and thrombocytopenia following a single dose of Janssen Ad26.COV2.S vaccination. Curcio R; Gandolfo V; Alcidi R; Giacomino L; Campanella T; Casarola G; Rossi R; Chiatti L; D'Abbondanza M; Commissari R; Gresele P; Pucci G; Vaudo G Int J Infect Dis; 2022 Mar; 116():154-156. PubMed ID: 34986404 [TBL] [Abstract][Full Text] [Related]
52. Management of a severe bilateral pulmonary embolism as a complication of VITT following vaccination with AstraZeneca COVID-19 vaccine. Elkoumy M; Schoen J; Loew A BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35545306 [TBL] [Abstract][Full Text] [Related]
57. Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine. van der Neut Kolfschoten M; Inganäs H; Perez-Peinado C; Calado da Silva Freire J; Melchers JM; van Dijk N; Przeradzka M; Kourkouta E; van Manen D; Vellinga J; Custers J; Bos R J Thromb Haemost; 2024 Apr; 22(4):1046-1055. PubMed ID: 38159648 [TBL] [Abstract][Full Text] [Related]
59. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia. Huynh A; Arnold DM; Ivetic N; Clare R; Hadzi-Tosev M; Liu Y; Smith JW; Bissola AL; Daka M; Kelton JG; Nazy I J Thromb Haemost; 2023 Oct; 21(10):2833-2843. PubMed ID: 37394121 [TBL] [Abstract][Full Text] [Related]